IRCCS Humanitas Research Hospital & Humanitas University
Published February 3, 2021 | Version v1
Dataset Restricted

Dataset related to article "Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group"

Authors/Creators

  • 1. Department of Biomedical Sciences, Humanitas University, Milan, Italy
  • 2. Radiation Oncology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • 3. Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.
  • 4. Radiation Oncology, Cyberknife Center, Centro Diagnostico Italiano, Milan, Italy
  • 5. Department of Oncology, Radiation Oncology, School of Medicine, University of Turin, Turin, Italy.
  • 6. Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • 7. Radiation Oncology, Cyberknife Center, Centro Diagnostico Italiano, Milan, Italy.
  • 8. Radiation Oncology Unit, Istituto Nazionale per la cura e lo studio dei tumori, Fondazione G. Pascale, Napoli, Ital
  • 9. adiotherapy Department, Ivrea Community Hospital, Ivrea (Turin), Italy.
  • 10. Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
  • 11. Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCSS, Aviano, Italy
  • 12. Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Description

This record contains raw data related to article "Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group"

Objectives: The role of radiotherapy (RT) for oligometastases is currently established in different oncological settings but data on salivary gland cancer (SGC) are lacking. We evaluated the role of RT in oligometastatic SGC patients, focusing on stereotactic body radiation therapy (SBRT).

Materials and methods: We performed a retrospective, multicentric study of oligometastatic SGC treated with palliative RT or SBRT. Endpoints included response evaluation and local control (LC).

Results: Between 2006 and 2016, 64 patients were collected from 9 Italian Cancer Centers, on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Working Group. 37 patients (57.8%) were suffering from adenoid cystic carcinoma (ACC) and 27 patients (42.2%) had non-ACC. Thirty-four patients underwent palliative RT (53,1%), and 30 received SBRT (46,9%). Most common metastatic sites were bone for palliative RT and lung for SBRT. Among patients treated with SBRT, an objective response or a stability was observed in all treated lesions. After a median follow-up of 29.2 months (range 2.3-117.1), LC at 12 months was 57.5% for patients treated with SBRT and was higher in ACC subgroup.

Conclusion: We confirmed the potential role of SBRT in the management of oligometastatic SGC patients to control limited burden of disease considering the absence of effective systemic therapies.

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/4498361">Log in</a> to check if you have access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

This set of data is accessible only upon request because it includes sensitive data.
Please write your request to biblioteca@humanitas.it

You are currently not logged in. Do you have an account? Log in here

Additional details

Related works

Is supplement to
10.1111/odi.13755 (DOI)
33320410 (ean8)